New survey highlights persistent cancer medication shortages across United States
The National Comprehensive Cancer Network (NCCN)—an alliance of leading cancer centers—has published updated data on the current impact of generic cancer medication shortages in the United States. The data come from survey responses from pharmacy directors and other clinical and administrative leaders at NCCN Member Institutions from late August. According to the results, 100% of responding…
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
